Announcements

9 articles

AUSTRALIA & NEW ZEALAND SITE SOLUTIONS SUMMIT

  • 10 November 2022

Melbourne, Australia

2023 ARCS Annual Conference (6 – 8 June 2023)

  • 10 November 2022

The 2023 ARCS Annual Conference (6 – 8 June 2023) will be held at the International Convention Centre (ICC), Darling Harbour, Sydney.

9th VERVE Symposium in Sydney in December

  • 10 November 2022

Welcome to the NEXT LEVEL in VASCULAR EDUCATION

VEITHsymposium November 2022

  • 6 August 2022

49th Annual Symposium on Vascular and Endovascular Issues

Clinical Feasibility Study for Endovenous Deep Vein Valve Formation for Chronic Venous Insufficiency

  • 18 June 2019

Initial Results. Mr. Thodur Vasudevan, Clinical Trials NZ

SABER™ Bupivacaine, a novel extended-release formulation of bupivacaine for postoperative pain control...

  • 15 October 2014

demonstrates dose-response, safety and no impact on surgical wound healing.

SABER™ Bupivacaine Reduces Postoperative Pain Intensity and Opioid Use for 72 Hours in Soft-Tissue and Bony Surgeries

  • 15 October 2014

Poster presentation American Society of Anaesthesiologists, October 15 2014

Intranasal Ketorolac (ROX-888) for Postoperative Pain: A Phase 3, Double-Blind, Randomized Study

  • 8 May 2008

Presented at the 2008 Society for Ambulatory Anesthesia Annual Meeting